FDA-Drug2026-10-14Class IIPROCESSING DEFECT

Carolina Infusion semaglutide/cyanocobalamin injectable recalled for sterility concerns

OTHERNationwide distributionDrugsBaby & kids

What this means

Carolina Infusion LLC is recalling compounded semaglutide/cyanocobalamin injectable syringes due to lack of assurance of sterility. The issue stems from the use of bacteriostatic water in formulation and concerns about processing equipment. The recall affects five specific lots distributed nationwide.

  • If you have received a syringe from Carolina Infusion with a lot number and expiration date matching those listed, do not use it.
  • Contact your healthcare provider or pharmacy immediately for guidance.
  • Do not dispose of the medication without asking your healthcare provider how to safely discard it.
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.

Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the U.S
Affected count
82.9 mls - in patient specific syringe dose
Manufactured in
95 Bees Creek Rd, N/A, Ridgeland, SC, United States
Products
SEMAGLUTIDE/CYANOCOBALAMIN 9/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0026-2027

More Carolina Infusion recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.